Does the media prefer NIOX or EKF?

In the previous week, EKF Diagnostics had 1 more articles in the media than NIOX Group. MarketBeat recorded 2 mentions for EKF Diagnostics and 1 mentions for NIOX Group. NIOX Group's average media sentiment score of 0.75 beat EKF Diagnostics' score of 0.71 indicating that NIOX Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NIOX Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive EKF Diagnostics 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer CREO or EKF?

In the previous week, Creo Medical Group and Creo Medical Group both had 2 articles in the media. EKF Diagnostics' average media sentiment score of 0.71 beat Creo Medical Group's score of 0.00 indicating that EKF Diagnostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Creo Medical Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral EKF Diagnostics 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend IUG or EKF?

EKF Diagnostics has a consensus target price of GBX 35, indicating a potential upside of 30.60%. Given EKF Diagnostics' stronger consensus rating and higher possible upside, analysts plainly believe EKF Diagnostics is more favorable than Intelligent Ultrasound Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Ultrasound Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 EKF Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Do analysts prefer NCYT or EKF?

EKF Diagnostics has a consensus price target of GBX 35, indicating a potential upside of 30.60%. Given EKF Diagnostics' stronger consensus rating and higher possible upside, analysts plainly believe EKF Diagnostics is more favorable than Novacyt. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Novacyt 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 EKF Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has stronger valuation & earnings, NCYT or EKF?

EKF Diagnostics has higher revenue and earnings than Novacyt. Novacyt is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Novacyt £20.03M 1.24 -£36.80M -£32.00 N/A EKF Diagnostics £51.56M 2.24 £4.68M £0.47 57.02

Is NCYT or EKF more profitable?

EKF Diagnostics has a net margin of 4.12% compared to Novacyt's net margin of -135.96%. EKF Diagnostics' return on equity of 3.01% beat Novacyt's return on equity. Company Net Margins Return on Equity Return on Assets Novacyt -135.96% -121.30% -27.98% EKF Diagnostics 4.12% 3.01% 5.27%

Does the media prefer NCYT or EKF?

In the previous week, EKF Diagnostics had 1 more articles in the media than Novacyt. MarketBeat recorded 2 mentions for EKF Diagnostics and 1 mentions for Novacyt. EKF Diagnostics' average media sentiment score of 0.71 beat Novacyt's score of 0.00 indicating that EKF Diagnostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Novacyt 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral EKF Diagnostics 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate EKF or IHC?

EKF Diagnostics presently has a consensus target price of GBX 35, suggesting a potential upside of 30.60%. Given EKF Diagnostics' stronger consensus rating and higher probable upside, analysts plainly believe EKF Diagnostics is more favorable than Inspiration Healthcare Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score EKF Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Inspiration Healthcare Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

EKF Diagnostics (EKF) Competitors

GBX 26.80 -0.20 (-0.74%)

As of 11:55 AM Eastern

Compare

EKF vs. NIOX, CREO, IUG, NCYT, and IHC

Should you buy EKF Diagnostics stock or one of its competitors? MarketBeat compares EKF Diagnostics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with EKF Diagnostics include NIOX Group (NIOX), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), and Inspiration Healthcare Group (IHC). These companies are all part of the "medical devices" industry.

How does EKF Diagnostics compare to NIOX Group?

NIOX Group (LON:NIOX) and EKF Diagnostics (LON:EKF) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment and valuation.

In the previous week, EKF Diagnostics had 1 more articles in the media than NIOX Group. MarketBeat recorded 2 mentions for EKF Diagnostics and 1 mentions for NIOX Group. NIOX Group's average media sentiment score of 0.75 beat EKF Diagnostics' score of 0.71 indicating that NIOX Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NIOX Group	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
EKF Diagnostics	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NIOX Group has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market. Comparatively, EKF Diagnostics has a beta of 0.516, suggesting that its stock price is 48% less volatile than the broader market.

NIOX Group has higher earnings, but lower revenue than EKF Diagnostics. NIOX Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NIOX Group	£48.70M	4.80	£995.88M	£1.64	33.90
EKF Diagnostics	£51.56M	2.24	£4.68M	£0.47	57.02

NIOX Group has a net margin of 14.37% compared to EKF Diagnostics' net margin of 4.12%. NIOX Group's return on equity of 10.14% beat EKF Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NIOX Group	14.37%	10.14%	3.95%
EKF Diagnostics	4.12%	3.01%	5.27%

NIOX Group currently has a consensus price target of GBX 86, indicating a potential upside of 54.68%. EKF Diagnostics has a consensus price target of GBX 35, indicating a potential upside of 30.60%. Given NIOX Group's higher possible upside, research analysts plainly believe NIOX Group is more favorable than EKF Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
EKF Diagnostics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

7.6% of NIOX Group shares are held by institutional investors. Comparatively, 22.2% of EKF Diagnostics shares are held by institutional investors. 5.1% of NIOX Group shares are held by company insiders. Comparatively, 39.9% of EKF Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

NIOX Group beats EKF Diagnostics on 8 of the 14 factors compared between the two stocks.

How does EKF Diagnostics compare to Creo Medical Group?

Creo Medical Group (LON:CREO) and EKF Diagnostics (LON:EKF) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment and valuation.

Creo Medical Group has a beta of 1.6246382, suggesting that its stock price is 62% more volatile than the broader market. Comparatively, EKF Diagnostics has a beta of 0.516, suggesting that its stock price is 48% less volatile than the broader market.

EKF Diagnostics has higher revenue and earnings than Creo Medical Group. Creo Medical Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Creo Medical Group	£6M	11.84	-£25.04M	£1.00	14.63
EKF Diagnostics	£51.56M	2.24	£4.68M	£0.47	57.02

Creo Medical Group has a net margin of 88.33% compared to EKF Diagnostics' net margin of 4.12%. Creo Medical Group's return on equity of 9.56% beat EKF Diagnostics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Creo Medical Group	88.33%	9.56%	-20.09%
EKF Diagnostics	4.12%	3.01%	5.27%

44.1% of Creo Medical Group shares are held by institutional investors. Comparatively, 22.2% of EKF Diagnostics shares are held by institutional investors. 6.4% of Creo Medical Group shares are held by company insiders. Comparatively, 39.9% of EKF Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Creo Medical Group currently has a consensus price target of GBX 40, indicating a potential upside of 173.50%. EKF Diagnostics has a consensus price target of GBX 35, indicating a potential upside of 30.60%. Given Creo Medical Group's higher possible upside, research analysts plainly believe Creo Medical Group is more favorable than EKF Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Creo Medical Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
EKF Diagnostics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Creo Medical Group and Creo Medical Group both had 2 articles in the media. EKF Diagnostics' average media sentiment score of 0.71 beat Creo Medical Group's score of 0.00 indicating that EKF Diagnostics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Creo Medical Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
EKF Diagnostics	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

EKF Diagnostics beats Creo Medical Group on 8 of the 15 factors compared between the two stocks.

How does EKF Diagnostics compare to Intelligent Ultrasound Group?

Intelligent Ultrasound Group (LON:IUG) and EKF Diagnostics (LON:EKF) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership and valuation.

EKF Diagnostics has a net margin of 4.12% compared to Intelligent Ultrasound Group's net margin of -23.11%. EKF Diagnostics' return on equity of 3.01% beat Intelligent Ultrasound Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Ultrasound Group	-23.11%	-23.58%	-13.51%
EKF Diagnostics	4.12%	3.01%	5.27%

EKF Diagnostics has a consensus target price of GBX 35, indicating a potential upside of 30.60%. Given EKF Diagnostics' stronger consensus rating and higher possible upside, analysts plainly believe EKF Diagnostics is more favorable than Intelligent Ultrasound Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Ultrasound Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
EKF Diagnostics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, EKF Diagnostics had 2 more articles in the media than Intelligent Ultrasound Group. MarketBeat recorded 2 mentions for EKF Diagnostics and 0 mentions for Intelligent Ultrasound Group. EKF Diagnostics' average media sentiment score of 0.71 beat Intelligent Ultrasound Group's score of 0.00 indicating that EKF Diagnostics is being referred to more favorably in the news media.

Company	Overall Sentiment
Intelligent Ultrasound Group	Neutral
EKF Diagnostics	Positive

EKF Diagnostics has higher revenue and earnings than Intelligent Ultrasound Group. Intelligent Ultrasound Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Ultrasound Group	£6.57M	0.00	-£2.27M	-£0.68	N/A
EKF Diagnostics	£51.56M	2.24	£4.68M	£0.47	57.02

Intelligent Ultrasound Group has a beta of 0.38, indicating that its share price is 62% less volatile than the broader market. Comparatively, EKF Diagnostics has a beta of 0.516, indicating that its share price is 48% less volatile than the broader market.

75.5% of Intelligent Ultrasound Group shares are held by institutional investors. Comparatively, 22.2% of EKF Diagnostics shares are held by institutional investors. 12.8% of Intelligent Ultrasound Group shares are held by insiders. Comparatively, 39.9% of EKF Diagnostics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

EKF Diagnostics beats Intelligent Ultrasound Group on 14 of the 15 factors compared between the two stocks.

How does EKF Diagnostics compare to Novacyt?

Novacyt (LON:NCYT) and EKF Diagnostics (LON:EKF) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends.

EKF Diagnostics has a net margin of 4.12% compared to Novacyt's net margin of -135.96%. EKF Diagnostics' return on equity of 3.01% beat Novacyt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Novacyt	-135.96%	-121.30%	-27.98%
EKF Diagnostics	4.12%	3.01%	5.27%

10.7% of Novacyt shares are held by institutional investors. Comparatively, 22.2% of EKF Diagnostics shares are held by institutional investors. 0.7% of Novacyt shares are held by company insiders. Comparatively, 39.9% of EKF Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Novacyt has a beta of 1.105, indicating that its stock price is 11% more volatile than the broader market. Comparatively, EKF Diagnostics has a beta of 0.516, indicating that its stock price is 48% less volatile than the broader market.

EKF Diagnostics has a consensus price target of GBX 35, indicating a potential upside of 30.60%. Given EKF Diagnostics' stronger consensus rating and higher possible upside, analysts plainly believe EKF Diagnostics is more favorable than Novacyt.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Novacyt	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
EKF Diagnostics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

EKF Diagnostics has higher revenue and earnings than Novacyt. Novacyt is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Novacyt	£20.03M	1.24	-£36.80M	-£32.00	N/A
EKF Diagnostics	£51.56M	2.24	£4.68M	£0.47	57.02

In the previous week, EKF Diagnostics had 1 more articles in the media than Novacyt. MarketBeat recorded 2 mentions for EKF Diagnostics and 1 mentions for Novacyt. EKF Diagnostics' average media sentiment score of 0.71 beat Novacyt's score of 0.00 indicating that EKF Diagnostics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Novacyt	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
EKF Diagnostics	0 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

EKF Diagnostics beats Novacyt on 15 of the 16 factors compared between the two stocks.

How does EKF Diagnostics compare to Inspiration Healthcare Group?

EKF Diagnostics (LON:EKF) and Inspiration Healthcare Group (LON:IHC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability.

EKF Diagnostics has a net margin of 4.12% compared to Inspiration Healthcare Group's net margin of -2.19%. EKF Diagnostics' return on equity of 3.01% beat Inspiration Healthcare Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EKF Diagnostics	4.12%	3.01%	5.27%
Inspiration Healthcare Group	-2.19%	-6.49%	-3.47%

EKF Diagnostics has a beta of 0.516, indicating that its share price is 48% less volatile than the broader market. Comparatively, Inspiration Healthcare Group has a beta of 0.867, indicating that its share price is 13% less volatile than the broader market.

22.2% of EKF Diagnostics shares are held by institutional investors. Comparatively, 7.4% of Inspiration Healthcare Group shares are held by institutional investors. 39.9% of EKF Diagnostics shares are held by company insiders. Comparatively, 8.4% of Inspiration Healthcare Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, EKF Diagnostics had 2 more articles in the media than Inspiration Healthcare Group. MarketBeat recorded 2 mentions for EKF Diagnostics and 0 mentions for Inspiration Healthcare Group. EKF Diagnostics' average media sentiment score of 0.71 beat Inspiration Healthcare Group's score of 0.00 indicating that EKF Diagnostics is being referred to more favorably in the media.

Company	Overall Sentiment
EKF Diagnostics	Positive
Inspiration Healthcare Group	Neutral

EKF Diagnostics has higher revenue and earnings than Inspiration Healthcare Group. Inspiration Healthcare Group is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EKF Diagnostics	£51.56M	2.24	£4.68M	£0.47	57.02
Inspiration Healthcare Group	£45.20M	0.42	-£12.20M	-£13.65	N/A

EKF Diagnostics presently has a consensus target price of GBX 35, suggesting a potential upside of 30.60%. Given EKF Diagnostics' stronger consensus rating and higher probable upside, analysts plainly believe EKF Diagnostics is more favorable than Inspiration Healthcare Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EKF Diagnostics	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Inspiration Healthcare Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

EKF Diagnostics beats Inspiration Healthcare Group on 15 of the 16 factors compared between the two stocks.

Get EKF Diagnostics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EKF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EKF vs. The Competition

Export

Metric	EKF Diagnostics	Medical Devices Industry	Medical Sector	LON Exchange
Market Cap	£115.38M	£2.08B	£6.85B	£2.78B
Dividend Yield	4.65%	2.68%	2.66%	6.14%
P/E Ratio	57.02	14.62	26.04	366.54
Price / Sales	2.24	126.85	550.17	85,951.69
Price / Cash	10.64	15.99	29.09	27.87
Price / Book	1.74	4.46	10.98	7.75
Net Income	£4.68M	£144.75M	£3.57B	£5.89B
7 Day Performance	2.54%	0.93%	3.06%	-1.01%
1 Month Performance	-0.48%	-0.91%	0.72%	-1.74%
1 Year Performance	N/A	0.38%	36.82%	65.54%

EKF Diagnostics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EKF EKF Diagnostics	2.6429 of 5 stars	GBX 26.80 -0.7%	GBX 35 +30.6%	+0.7%	£115.38M	£51.56M	57.02	356	News Coverage
NIOX NIOX Group	3.1387 of 5 stars	GBX 57 -1.0%	GBX 86 +50.9%	-15.6%	£242.42M	£48.70M	34.76	92	Gap Down
CREO Creo Medical Group	N/A	GBX 13.45 -0.4%	GBX 40 +197.4%	+1.5%	£66.19M	£6M	13.45	279	News Coverage Analyst Forecast High Trading Volume
IUG Intelligent Ultrasound Group	N/A	N/A	N/A	N/A	£42.76M	£6.57M	N/A	65
NCYT Novacyt	N/A	GBX 33.90 -3.1%	N/A	-21.4%	£25.12M	£20.03M	N/A	120

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:EKF) was last updated on 6/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

EKF Diagnostics (EKF) Competitors

EKF vs. NIOX, CREO, IUG, NCYT, and IHC

How does EKF Diagnostics compare to NIOX Group?

Summary

How does EKF Diagnostics compare to Creo Medical Group?

Summary

How does EKF Diagnostics compare to Intelligent Ultrasound Group?

Summary

How does EKF Diagnostics compare to Novacyt?

Summary

How does EKF Diagnostics compare to Inspiration Healthcare Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EKF vs. The Competition

EKF Diagnostics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

EKF Diagnostics (EKF) Competitors

EKF vs. NIOX, CREO, IUG, NCYT, and IHC

How does EKF Diagnostics compare to NIOX Group?

Does the media prefer NIOX or EKF?

Which has more risk and volatility, NIOX or EKF?

Which has preferable valuation & earnings, NIOX or EKF?

Is NIOX or EKF more profitable?

Do analysts recommend NIOX or EKF?

Do insiders and institutionals hold more shares of NIOX or EKF?

Summary

How does EKF Diagnostics compare to Creo Medical Group?

Which has more risk and volatility, CREO or EKF?

Which has preferable valuation & earnings, CREO or EKF?

Is CREO or EKF more profitable?

Do insiders and institutionals hold more shares of CREO or EKF?

Do analysts recommend CREO or EKF?

Does the media prefer CREO or EKF?

Summary

How does EKF Diagnostics compare to Intelligent Ultrasound Group?

Is IUG or EKF more profitable?

Do analysts recommend IUG or EKF?

Does the media refer more to IUG or EKF?

Which has stronger valuation & earnings, IUG or EKF?

Which has more risk and volatility, IUG or EKF?

Do insiders and institutionals believe in IUG or EKF?

Summary

How does EKF Diagnostics compare to Novacyt?

Is NCYT or EKF more profitable?

Do institutionals & insiders believe in NCYT or EKF?

Which has more risk and volatility, NCYT or EKF?

Do analysts prefer NCYT or EKF?

Which has stronger valuation & earnings, NCYT or EKF?

Does the media prefer NCYT or EKF?

Summary

How does EKF Diagnostics compare to Inspiration Healthcare Group?

Is EKF or IHC more profitable?

Which has more risk & volatility, EKF or IHC?

Do institutionals and insiders believe in EKF or IHC?

Does the media favor EKF or IHC?

Which has better earnings & valuation, EKF or IHC?

Do analysts rate EKF or IHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EKF vs. The Competition

EKF Diagnostics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools